FOSAVANCE DIN 02314940
Status: Marketed
Holder: ORGANON CANADA INC.
Available to quote
Health Canada record
| Active ingredient(s) | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 5600 UNIT |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M05BB03 ALENDRONIC ACID AND CHOLECALCIFEROL |
| Original market date | 17-Sep-2008 |
| Current status date | 05-Jul-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Organon Canada Inc. — licence 3-002674, currently licensed, last inspection rating C (2025-11-06).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02276429 | FOSAVANCE | ORGANON CANADA INC. | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 2800 UNIT | Marketed |
| 02519836 | JAMP ALENDRONATE / VITAMIN D3 | JAMP PHARMA CORPORATION | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 5600 UNIT | Marketed |
| 02519828 | JAMP ALENDRONATE / VITAMIN D3 | JAMP PHARMA CORPORATION | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 2800 UNIT | Marketed |
| 02258102 | ACT ALENDRONATE | ACTAVIS PHARMA COMPANY | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 40 MG | Cancelled Post Market |
| 02258110 | ACT ALENDRONATE | ACTAVIS PHARMA COMPANY | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Post Market |
| 02343916 | ALENDRONATE | COBALT PHARMACEUTICALS COMPANY | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 40 MG | Cancelled Pre Market |
| 02343924 | ALENDRONATE | COBALT PHARMACEUTICALS COMPANY | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Pre Market |
| 02405717 | ALENDRONATE-CHOLECALCIFEROL | FROSST A DIVISION OF MERCK CANADA INC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 2800 UNIT | Cancelled Pre Market |
| 02405725 | ALENDRONATE-CHOLECALCIFEROL | FROSST A DIVISION OF MERCK CANADA INC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 5600 UNIT | Cancelled Pre Market |
| 02248625 | FOSAMAX | MERCK CANADA INC | Solution | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Post Market |
| 02270110 | GEN-ALENDRONATE | GENPHARM ULC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 5 MG | Cancelled Post Market |
| 02286335 | MYLAN-ALENDRONATE | MYLAN PHARMACEUTICALS ULC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Post Market |
| 02270129 | MYLAN-ALENDRONATE | MYLAN PHARMACEUTICALS ULC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 10 MG | Cancelled Post Market |
| 02372304 | Q-ALENDRONATE | QD PHARMACEUTICALS ULC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Post Market |
| 02270870 | RIVA ALENDRONATE | LABORATOIRE RIVA INC. | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 40 MG | Cancelled Pre Market |
| 02429160 | SANDOZ ALENDRONATE/CHOLECALCIFEROL | SANDOZ CANADA INCORPORATED | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 5600 UNIT | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25853 | 2021-05-12 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 9703 | 2008-08-06 | Supplement to a New Drug Submission (SNDS) | NEW STRENGTH: 70mg/140mcg |